Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06219278 · ClinicalTrials.gov registry record
A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles
A clinical trial, sponsored by Candela Corporation.
- Completed
- Registry status
- 32
- Enrollment target
NCT06219278 is a clinical trial that has completed, run by Candela Corporation. The registered enrollment target is 32 participants.
The verdict
NCT06219278 has completed, sponsored by Candela Corporation.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
This is a retrospective chart review of data from the multi-site prospective clinical trial, "Functional Usability and Feasibility Testing of the Profound Matrix™ System (FUFT2002)" to evaluate the safety and efficacy of the Profound Matrix System Matrix Pro applicator for the treatment of wrinkles.
Interventions
- DEVICE Profound Matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-10-29 |
| Est. Completion | 2024-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06219278
The ClinicalTrials.gov registry entry for NCT06219278 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Candela Corporation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Profound Matrix is the first listed.
NCT06219278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06219278 about?
NCT06219278 is a clinical study titled "A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles". This is a retrospective chart review of data from the multi-site prospective clinical trial, "Functional Usability and Feasibility Testing of the Profound Matrix™ System (FUFT2002)" to evaluate the safety and efficacy of the Profound Matrix System Matrix Pro applicator for the treatment of wrinkles.
What is the current status of trial NCT06219278?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2023-10-29. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT06219278?
The interventions under investigation include: Profound Matrix (DEVICE).
Who is sponsoring clinical trial NCT06219278?
This trial is sponsored by Candela Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.